MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0055858
Aptra Synthesis Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.84 Cr
▼ 24% YoY
Net profit · FY 2024
₹9.23 Lakh
Net margin 1%
EBITDA · FY 2024
₹88.59 Lakh
EBITDA margin 10%
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹7.13 Cr
Issued & subscribed
Open charges
₹23 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Aptra Synthesis Private Limited
Data last updated:
Aptra Synthesis Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2020PTC140420. Its GSTIN is 36AATCA4857B1ZH (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹7.13 Cr. It is led by directors Chaitanya Kumar Reddy Marram Reddy and Narendra Babu Mandalapu.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.74 H.No.5 – 5 – 35/18/1&3 4th Floor Mythri Towers Apiic Rd Prashanti Nagar, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.84 Cr, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹9.23 Lakh (net margin 1%) and EBITDA of ₹88.59 Lakh (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 184% over three years.
As per MCA filings, the company has open charges of ₹23 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 5 cases are pending. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in July 2022. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Proventus Life Sciences Private Limited with revenue of ₹9.17 Cr.
Aptra Synthesis Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0055858). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aptrasynthesis.com.
Company details
CIN U24304TG2020PTC140420
Registration Number 140420
Incorporation Date 23 May 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0055858
Recognitions & Rankings of Aptra Synthesis
Contact details
Aptra Synthesis Private Limited's registered office is in Hyderabad, Telangana. Its website is aptrasynthesis.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.74 H.No.5 – 5 – 35/18/1&3 4th Floor Mythri Towers Apiic Rd Prashanti Nagar, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aptra Synthesis Private Limited, buy the company report.
Comprehensive company report
Aptra Synthesis Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aptra Synthesis is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aptra Synthesis Private Limited, buy the company report.
Financials of Aptra Synthesis Private Limited
FY 2024 filings availableAptra Synthesis Private Limited reported revenue of ₹8.84 Cr (down 24% YoY) for FY 2024.
Revenue · FY 2024
₹8.84 Cr ▼ 24%
Net profit · FY 2024
₹9.23 Lakh margin 1%
EBITDA · FY 2024
₹88.59 Lakh margin 10%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 24%
3 years · compounded
▲ 184%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 181%
Revenue fell 24% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 184%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹88.59 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹9.23 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 10% | |||
| Net Profit Margin | 1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aptra Synthesis Private Limited, buy the company report.
Board of directors of Aptra Synthesis Private Limited
Aptra Synthesis has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chaitanya Kumar Reddy Marram Reddy Also directs: Aeson Hospitality LLP, Aptra Pharmachem Private Limited, Voc AI Electronics Bharath Private Limited and 2 more | Director | 23 May 2020 | 6 Years 5 Months | Current |
| Narendra Babu Mandalapu Also directs: Aptra Pharmachem Private Limited, Indifarms Private Limited, PGR Systems & Technologies Private Limited and 1 more | Director | 23 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Aptra Synthesis Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Proventus Life Sciences Private Limited | ₹9.17 Cr (FY 2024) | -47.0% | Chennai, Tamil Nadu, India | |||
| Thexa Pharma Private Limited | ₹9.03 Cr (FY 2018) | -84.0% | Madgul, Telangana, India | |||
| Xenocor Pharmalab Private Limited | ₹8.98 Cr (FY 2024) | 75.0% | Bangalore, Karnataka, India | |||
| Aptra Synthesis Private Limitedthis company | ₹8.84 Cr (FY 2024) | ₹9.23 Lakh | 1% | -24.0% | Hyderabad, Telangana, India | |
| Chiral Drugs Pvt Ltd | ₹8.77 Cr (FY 2024) | -35.0% | Surat, Gujarat, India | |||
| Prajna Generics Private Limited | ₹8.64 Cr (FY 2022) | 3.0% | Telangana, India |
To see the full peer comparison of Aptra Synthesis Private Limited, buy the company report.
Auditor
Aptra Synthesis Private Limited is audited by GMS & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GMS & ASSOCIATES | FY 2023 | 014660S |
Shareholding
The shareholding of Aptra Synthesis Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aptra Synthesis Private Limited, buy the company report.
Charges & borrowings
Open charges
₹23 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jan 2024 | 100872746 | Hdfc Bank Limited | ₹23 Cr | Open |
To see the full charge records of Aptra Synthesis Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Aptra Synthesis Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in July 2022.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2022 | Rights issue | ₹7.12 Cr | Investors: 2 individuals |
| Jul 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aptra Synthesis Private Limited has 5 court cases on record: 1 filed by Aptra Synthesis, 4 filed against it. All cases are pending.
Total cases
5
Filed by the company
1
Filed against the company
4
Pending
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 4 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Amjey Chem Trade Private Limited Through Its Auth. Rep. Manish Jhanwar | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by M/S. Dimerco Express India Private Limited | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by Aditya Birla Capital Limited | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against The Assistant Commissioner (St) | Pending |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed against the company by M/S Amma Scientific Enterprises Rep by M Narasimulu | Pending |
To see the full case history of Aptra Synthesis Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aptra Synthesis Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aptra Synthesis Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
Aptra Synthesis has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCA4857B1ZH | Telangana | Active | 04 Jun 2020 |
| 37AATCA4857B1ZF | Andhra Pradesh | Active | 23 Apr 2022 |
To see the full GST registrations and return filing status of Aptra Synthesis Private Limited, buy the company report.
Recent activity
Aptra Synthesis Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Biddala Madhukar Reddy ceased to be Director on 22 Aug 2022.
AGM
Aptra Synthesis Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 23.00 Cr registered on 22 Jan 2024 with Charge ID 100872746 was modified on 16 May 2024.
Filing
Aptra Synthesis Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.00 Cr with Charge ID 100872746 was registered on 22 Jan 2024.
Ceased
Biddala Madhukar Reddy ceased to be Director.
Appointed
Chaitanya Kumar Reddy Marram Reddy was appointed as Director.
Appointed
Narendra Babu Mandalapu was appointed as Director.
Incorporation
23 May 2020
Aptra Synthesis Private Limited was registered on 23 May 2020 with Roc Hyderabad & aged 6 years 5 months as per MCA records.
Frequently asked questions
Aptra Synthesis is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 May 2020 (6+ years old) and is registered under CIN U24304TG2020PTC140420.
Aptra Synthesis has 2 current directors:
- Chaitanya Kumar Reddy Marram Reddy - Director
- Narendra Babu Mandalapu - Director
The latest financial statements of Aptra Synthesis on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aptra Synthesis is 36AATCA4857B1ZH, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AATCA4857B1ZF (Andhra Pradesh).
The CIN (Corporate Identification Number) of Aptra Synthesis is U24304TG2020PTC140420. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aptra Synthesis has 5 court cases on record: 1 filed by the company and 4 filed against it. 5 are pending. Most are in the district courts.
Aptra Synthesis was incorporated on 23 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aptra Synthesis has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in July 2022.
The peers of Aptra Synthesis by revenue are Proventus Life Sciences Private Limited, Thexa Pharma Private Limited, Xenocor Pharmalab Private Limited, Chiral Drugs Pvt Ltd, Prajna Generics Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Biddala Madhukar Reddy ceased to be Director on 22 Aug 2022. Chaitanya Kumar Reddy Marram Reddy was appointed as Director on 23 May 2020. Narendra Babu Mandalapu was appointed as Director on 23 May 2020.
Yes, Aptra Synthesis is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0055858).